A recent study reported that an oncolytic virus called CD19t could induce tumor cells to express CD19 on their surface before killing them, subsequently redirecting CD19-CAR-T cytotoxicity and enhancing the anti-tumor response in mouse models (132). Here, CD19 is linked to neoplasm.